UP
UPH.F U.S. Physical Therapy Inc
- Market cap
- EUR 1.33B
- P/E
- -
- P/B
- 3.44x
- ROE
- -8.7%
- Dividend yield
- 1.86%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is UPH.F undervalued?
Graham numberThe Graham number of U.S. Physical Therapy Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
U.S. Physical Therapy Inc fundamental analysis
No fundamental analysis for U.S. Physical Therapy Inc yet.
U.S. Physical Therapy Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About U.S. Physical Therapy Inc
U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention servi…
Full company profileU.S. Physical Therapy Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
U.S. Physical Therapy Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 357M | 414M | 454M | 482M | 423M | 495M | 553M | 605M | 671M | 781M | 847M |
| Gross Profit | 82.0M | 90.6M | 102M | 112M | 94.5M | 117M | 112M | 122M | 124M | 150M | 157M |
| Operating Income | 49.5M | 54.7M | 60.3M | 67.4M | 65.9M | 75.2M | 65.9M | 70.0M | 65.6M | 80.4M | 83.5M |
| EBITDA | - | 64.5M | 72.0M | 83.1M | 77.7M | 85.7M | 76.1M | 74.4M | 86.9M | 110M | 105M |
| Net Income | 20.6M | 22.3M | 34.9M | 40.0M | 35.2M | 40.8M | 32.2M | 14.7M | 26.5M | 15.1M | -37.2M |
| EPS | - | 1.77 | 2.75 | 3.13 | 2.74 | 3.16 | 2.47 | 0.98 | 1.75 | 1.00 | -2.49 |
| Balance Sheet | |||||||||||
| Total Assets | 351M | 419M | 443M | 561M | 594M | 749M | 858M | 997M | 1.17B | 1.20B | 1.30B |
| Total Liabilities | 163M | 213M | 226M | 319M | 317M | 452M | 374M | 345M | 408M | 434M | 508M |
| Shareholders' Equity | 188M | 205M | 216M | 240M | 276M | 296M | 316M | 476M | 489M | 476M | 429M |
| Cash & Short-term Investments | 20.0M | 21.9M | 23.4M | 23.5M | 32.9M | 28.6M | 31.6M | 153M | 41.4M | 35.6M | 38.2M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 51.1M | 56.5M | 73.0M | 62.4M | 100.0M | 76.4M | 58.5M | 82.0M | 74.9M | 75.1M | 85.2M |
| Capital Expenditure | 8.26M | 7.10M | 7.19M | 10.2M | 7.64M | 8.20M | 8.25M | 9.29M | 9.19M | 14.1M | 21.1M |
| Free Cash Flow | - | 49.4M | 65.8M | 52.3M | 92.4M | 68.2M | 50.3M | 72.7M | 65.8M | 61.0M | 64.1M |
| Ratios | |||||||||||
| ROE | 11.0% | 10.9% | 16.1% | 16.7% | 12.7% | 13.8% | 10.2% | 3.1% | 5.4% | 3.2% | -8.7% |
| ROA | 5.9% | 5.3% | 7.9% | 7.1% | 5.9% | 5.4% | 3.7% | 1.5% | 2.3% | 1.3% | -2.9% |
| Net Profit Margin | 5.8% | 5.4% | 7.7% | 8.3% | 8.3% | 8.2% | 5.8% | 2.4% | 3.9% | 1.9% | -4.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
U.S. Physical Therapy Inc dividends
- Dividend yield
- 1.86%
- Forward dividend
- 1.65 EUR
- Payout ratio
- 181.7%
- Ex-dividend date
- Nov 16, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 27.4M | 1.81 | 181.7% |
| 2024 | USD 26.5M | 1.76 | 100.3% |
| 2023 | USD 24.1M | 1.61 | 164.4% |
| 2022 | USD 21.3M | 1.64 | 66.3% |
| 2021 | USD 18.8M | 1.45 | 46.0% |
| 2020 | USD 4.11M | 0.32 | 11.7% |
| 2019 | USD 14.6M | 1.14 | 36.4% |
| 2018 | USD 11.7M | 0.92 | 33.4% |
| 2017 | USD 10.1M | 0.80 | 45.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns U.S. Physical Therapy Inc
- Insiders 2.55%
- Institutions 97.45%
- Public & others 0.00%
- Shares outstanding 14.9M
- Free float 14.5M
U.S. Physical Therapy Inc company profile
- Company name
- U.S. Physical Therapy Inc
- Ticker
- UPH.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 4,653
- Fiscal year end
- December
- Address
- 1300 West Sam Houston Parkway South, Houston, TX, United States, 77042
- Phone
- 713 297 7000
- Website
- usph.com
About U.S. Physical Therapy Inc
U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.
U.S. Physical Therapy Inc management
10- Mr. Christopher J. ReadingCEO & Chairman · born 1964
- Mr. Eric Joseph WilliamsPresident & COO · born 1966
- Mr. Richard S. BinsteinExecutive VP, General Counsel & Secretary · born 1961
- Mr. Graham D. Reeve M.B.A., P.T.Chief Operating Officer - West · born 1964
- Mr. Michael G. MayrsohnCEO of Metro & Director · born 1987
- Mr. Nchacha E. EttaExecutive VP & CFO · born 1970
- Kate VenturinaVP of Accounting & Corporate Controller
- Mr. Chadd PenceChief Information Officer
- Ms. Jayne Fleck Pool ATC, PT, SCSSenior VP & Chief Compliance Officer
- Mr. Jason AndersonVice President of Human Resources